Flash Buy! Huge Year Ahead for This Small Eye Drug Developer
We have a fresh trade today! The company is developing eye therapies for dilation of the eyes with huge potential. With a Phase 3 catalyst date coming up, it only makes sense to jump in on this company today. Take action ASAP!
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Ray Blanco’s FDA Profit Alert
The FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.